BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion

Prostate cancer (PCa) that becomes resistant to hormone castration and next-generation androgen receptor (AR)-targeted therapies, called castration-resistant prostate cancer (CRPC), poses a significant clinical challenge. A better understanding of PCa progression and key molecular mechanisms could b...

Descripción completa

Detalles Bibliográficos
Autores principales: Blee, Alexandra M., Liu, Shujun, Wang, Liguo, Huang, Haojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122392/
https://www.ncbi.nlm.nih.gov/pubmed/27223260
http://dx.doi.org/10.18632/oncotarget.9513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122392/
https://www.ncbi.nlm.nih.gov/pubmed/27223260
http://dx.doi.org/10.18632/oncotarget.9513

Ejemplares similares